Literature DB >> 848361

Spontaneous systemic lupus erythematosus and acelylator phenotype.

R Larsson, E Karlsson, L Molin.   

Abstract

Fifteen patients with spontaneous systemic lupus erythematosus (SLE) have been phenotyped by determination of plasma isoniazid (INH) half-life. Seven patients had signs of renal insufficiency. Of the 15 patients, 13 were slow and only 2 rapid acetylators. No correlation was found between the plasma INH half-lives and the renal function. Thus, there is the same marked predominance of slow acetylators in patients with spontaneous SLE as in patients with the drug-induced SLE-like syndrome.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 848361     DOI: 10.1111/j.0954-6820.1977.tb15686.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  13 in total

1.  Clinical pharmacokinetics of hydrallazine.

Authors:  T Talseth
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

Review 2.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

3.  Hydralazine-induced peripheral neuropathy seen in a Japanese slow acetylator patient.

Authors:  G Tsujimoto; Y Horai; T Ishizaki; K Itoh
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

Review 4.  Drug metabolites in renal failure: pharmacokinetic and clinical implications.

Authors:  R K Verbeeck; R A Branch; G R Wilkinson
Journal:  Clin Pharmacokinet       Date:  1981 Sep-Oct       Impact factor: 6.447

5.  Hepatic acetylator phenotype in porphyria cutanea tarda.

Authors:  J M Ladero; R Enriquez de Salamanca; S Chinarro
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

6.  Tuberculosis in patients having dialysis.

Authors:  D A Mitchison; G A Ellard
Journal:  Br Med J       Date:  1980-06-21

7.  Lack of correlation between acetylator status and the production of the acetyl metabolite of acebutolol in man.

Authors:  A Gulaid; I M James; C M Kaye; O R Lewellen; E Roberts; M Sankey; J Smith; R Templeton; R J Thomas
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

Review 8.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

9.  Acetylator phenotype in spontaneous SLE and rheumatoid arthritis.

Authors:  D H Lawson; D A Henry; J Lowe; P Reavey; J A Rennie; A Solomon
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

Review 10.  Acetylator phenotype and lupus erythematosus.

Authors:  J P Uetrecht; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.